[
  {
    "ts": null,
    "headline": "BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket",
    "summary": "Bio-Rad witnesses growth across the Clinical Diagnostics segment in the fourth quarter, primarily driven by an increased demand for quality control and blood typing products.",
    "url": "https://finnhub.io/api/news?id=ce80e2823ec21d70ba0d8523012e3f8ac621ace2e525d0cd84d1911834b8aae5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739559420,
      "headline": "BIO Q4 Earnings and Revenues Miss Estimates, Stock Down Aftermarket",
      "id": 132743929,
      "image": "https://media.zenfs.com/en/zacks.com/62a1df11c94046acffed2654620317fb",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Bio-Rad witnesses growth across the Clinical Diagnostics segment in the fourth quarter, primarily driven by an increased demand for quality control and blood typing products.",
      "url": "https://finnhub.io/api/news?id=ce80e2823ec21d70ba0d8523012e3f8ac621ace2e525d0cd84d1911834b8aae5"
    }
  }
]